MacroGenics - 12 Year Stock Price History | MGNX
Historical daily share price chart and data for MacroGenics since 2013 adjusted for splits and dividends. The latest closing stock price for MacroGenics as of May 21, 2025 is 1.49.
- The all-time high MacroGenics stock closing price was 40.21 on January 17, 2014.
- The MacroGenics 52-week high stock price is 5.77, which is 287.2% above the current share price.
- The MacroGenics 52-week low stock price is 0.99, which is 33.6% below the current share price.
- The average MacroGenics stock price for the last 52 weeks is 3.20.
| MacroGenics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 2.1761 | 3.3000 | 3.4900 | 1.0600 | 1.4900 | -54.15% |
| 2024 | 7.9974 | 10.1800 | 21.4700 | 3.0000 | 3.2500 | -66.22% |
| 2023 | 6.0200 | 6.3600 | 10.1100 | 4.4800 | 9.6200 | 43.37% |
| 2022 | 6.3770 | 16.9000 | 16.9000 | 2.2500 | 6.7100 | -58.19% |
| 2021 | 24.0973 | 22.2000 | 35.6300 | 15.9100 | 16.0500 | -29.79% |
| 2020 | 19.2817 | 10.7800 | 31.6000 | 4.2800 | 22.8600 | 110.11% |
| 2019 | 14.6499 | 12.6600 | 25.6000 | 7.9450 | 10.8800 | -14.33% |
| 2018 | 21.2063 | 19.4200 | 32.4600 | 11.7500 | 12.7000 | -33.16% |
| 2017 | 18.5854 | 19.8200 | 22.1700 | 15.3100 | 19.0000 | -7.05% |
| 2016 | 24.1824 | 29.4100 | 32.3700 | 15.1500 | 20.4400 | -34.00% |
| 2015 | 32.1013 | 35.1800 | 39.4400 | 20.5800 | 30.9700 | -11.69% |
| 2014 | 25.3859 | 28.8300 | 40.2100 | 17.7800 | 35.0700 | 27.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.099B | $0.150B |
| MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.226B | 28.28 |
| Boston Scientific (BSX) | United States | $157.620B | 39.46 |
| Stryker (SYK) | United States | $148.687B | 31.09 |
| EssilorLuxottica (ESLOY) | France | $134.580B | 0.00 |
| Medtronic (MDT) | Ireland | $110.773B | 16.17 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.060B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.664B | 28.26 |
| ResMed (RMD) | United States | $36.384B | 27.33 |
| GE HealthCare Technologies (GEHC) | United States | $32.899B | 15.62 |
| Agilent Technologies (A) | United States | $32.353B | 21.37 |
| Terumo (TRUMY) | Japan | $27.583B | 35.83 |
| Insulet (PODD) | United States | $23.046B | 90.46 |
| Koninklijke Philips (PHG) | Netherlands | $22.521B | 16.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.865B | 12.12 |
| Baxter (BAX) | United States | $16.144B | 12.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.881B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.316B | 13.41 |
| Prestige Consumer Healthcare (PBH) | United States | $4.327B | 19.33 |
| Perrigo (PRGO) | Ireland | $3.770B | 9.55 |
| Haemonetics (HAE) | United States | $3.462B | 15.08 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| Envista Holdings (NVST) | United States | $3.012B | 25.03 |
| QuidelOrtho (QDEL) | United States | $2.190B | 15.06 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.80 |
| AtriCure (ATRC) | United States | $1.686B | 0.00 |
| Neogen (NEOG) | United States | $1.346B | 17.22 |
| Kestra Medical Technologies (KMTS) | United States | $1.280B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| BioLife Solutions (BLFS) | United States | $1.083B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.976B | 12.48 |
| InMode (INMD) | Israel | $0.933B | 9.40 |
| CeriBell (CBLL) | United States | $0.657B | 0.00 |
| Evolus (EOLS) | United States | $0.642B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.580B | 0.00 |
| Owens & Minor (OMI) | United States | $0.564B | 4.68 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.503B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.456B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.335B | 12.33 |
| Canopy Growth (CGC) | Canada | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.300B | 53.40 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 22.67 |
| Verano Holdings (VRNOF) | United States | $0.262B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.257B | 0.00 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 11.24 |
| Biote (BTMD) | United States | $0.218B | 6.12 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| Brainsway (BWAY) | Israel | $0.202B | 53.45 |
| Quanterix (QTRX) | United States | $0.194B | 0.00 |
| Omeros (OMER) | United States | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.34 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| Exagen (XGN) | United States | $0.127B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.123B | 0.00 |
| Agape ATP (ATPC) | $0.108B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| United Health Products (UEEC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.040B | 13.87 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.93 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Acuren (TIC) | United States | $0.000B | 0.00 |